Processa Pharmaceuticals Inc
General ticker "PCSA" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $3.5M
Processa Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -32.5%.
Estimated limits based on current volatility of 6.2%: low 0.83$, high 0.94$
Factors to consider:
- Current price 81.5% below estimated low
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [4.53$, 12.75$]
- 2024-12-30 to 2025-12-30 estimated range: [4.02$, 10.83$]
Financial Metrics affecting the PCSA estimates:
- Negative: Non-GAAP EPS, $ of -7.14 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -33.31 <= 2.35
- Negative: negative Net income
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Industry inventory ratio change (median), % of -2.41 <= -0.39
- Positive: Interest expense per share, $ of 0 <= 0
Short-term PCSA quotes
Long-term PCSA plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $12.13MM | $27.53MM | $11.46MM |
| Operating Income | $-12.13MM | $-27.53MM | $-11.46MM |
| Non-Operating Income | $0.18MM | $0.10MM | $0.34MM |
| Interest Expense | $0.00MM | $0.00MM | $0.00MM |
| R&D Expense | $6.88MM | $11.49MM | $5.80MM |
| Income(Loss) | $-11.96MM | $-27.42MM | $-11.12MM |
| Taxes | $-0.53MM | $0.00MM | $0.00MM |
| Profit(Loss) | $-11.43MM | $-27.42MM | $-11.12MM |
| Stockholders Equity | $25.49MM | $7.47MM | $4.99MM |
| Assets | $26.46MM | $8.62MM | $5.79MM |
| Operating Cash Flow | $-8.72MM | $-9.61MM | $-8.06MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $0.00MM | $0.00MM | $-0.00MM |
| Financing Cash Flow | $9.80MM | $-0.39MM | $6.27MM |
| Earnings Per Share* | $-15.00 | $-68.00 | $-8.48 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.